Broker Forecast - Liberum Capital issues a broker note on PureTech Health Plc

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Liberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 450p (from 420p).

Broker Forecasts data provided by www.sharesmagazine.co.uk